Saturday, February 7, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home AI & Quantum Computing

SoundHound AI Shares Tumble Despite Record Financial Performance

Robert Sasse by Robert Sasse
November 10, 2025
in AI & Quantum Computing, Earnings, Mergers & Acquisitions, Tech & Software
0
SoundHound AI Stock
0
SHARES
149
VIEWS
Share on FacebookShare on Twitter

SoundHound AI delivered what appeared to be an exceptional quarterly report, yet investors responded by sending shares sharply lower. The artificial intelligence company posted third-quarter revenue of $42 million, surpassing all expectations and prompting an upward revision to its annual forecast. Despite these positive operational metrics, the stock declined over 9% during Friday’s trading session. Market reaction focused on a $66 million accounting loss related to acquisition liabilities, overshadowing the company’s strong underlying business performance.

Strong Fundamentals Overshadowed by Non-Cash Charge

The voice AI specialist demonstrated impressive growth momentum with revenue surging 68% year-over-year, substantially exceeding analyst projections of $40-40.5 million. Management raised its full-year guidance to a range between $165 million and $180 million. Simultaneously, the company reaffirmed its target of achieving EBITDA profitability by the end of 2025.

However, market participants focused on the generally accepted accounting principles (GAAP) loss of $109.3 million, which included a $66 million non-cash adjustment for acquisition-related liabilities. This accounting entry represents a paper loss with no impact on the company’s cash position or liquidity. SoundHound AI concluded the quarter with a robust $269 million in cash reserves and maintains a debt-free balance sheet.

Strategic Expansion Gains Momentum

SoundHound AI continues to integrate recently acquired company Interactions, with the process expected to generate both cost efficiencies and revenue synergies. The company announced several significant business developments that underscore its market expansion:

Should investors sell immediately? Or is it worth buying SoundHound AI?

  • Collaboration with a major Chinese corporation to deploy technology across millions of smart devices
  • Automotive sector growth through partnerships with sports car manufacturers and electric vehicle brands
  • Restaurant industry expansion with national chain implementations
  • Strategic alliance with Telarus to distribute enterprise solutions

Product innovation remains central to the company’s strategy with the introduction of Amelia 7.3 and the new Vision AI platform. Looking further ahead, SoundHound AI plans to launch its Voice Commerce platform in 2026, enabling in-vehicle purchasing capabilities.

Market Experts Maintain Positive Outlook

Despite the stock trading below key technical levels and facing elevated short interest that amplifies price swings, financial analysts maintain constructive ratings on the equity. The consensus price target stands at $15.50 with a “Moderate Buy” recommendation. Investment firm H.C. Wainwright has reaffirmed its Buy rating with a more bullish $26 price objective.

The critical question for investors remains whether SoundHound AI can deliver on its promised EBITDA profitability timeline. For those confident in the company’s execution capabilities, the current price weakness may represent a potential entry point—provided the organization continues to validate its growth narrative through operational achievements.

Ad

SoundHound AI Stock: Buy or Sell?! New SoundHound AI Analysis from February 7 delivers the answer:

The latest SoundHound AI figures speak for themselves: Urgent action needed for SoundHound AI investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from February 7.

SoundHound AI: Buy or sell? Read more here...

Tags: SoundHound AI
Robert Sasse

Robert Sasse

About Dr. Robert Sasse Accomplished economist, entrepreneur, and profound expert in financial markets. Dr. Robert Sasse holds a doctorate in economics and combines academic rigor with practical entrepreneurial experience. His deep expertise in economic relationships and unwavering conviction for a free-market liberal economic order drives his mission to provide investors with well-founded knowledge and guidance.
Areas of Expertise:
  • Economic Theory and Practice
  • Free-Market Economics
  • Entrepreneurship and Business Strategy
  • Investment Philosophy
Dr. Sasse's unique combination of academic knowledge and real-world business experience enables him to provide investors with comprehensive insights that bridge theory and practice.

Related Posts

Orthofix Medical Stock
Earnings

Orthofix Medical Strengthens Scientific Foundation for Biologics Portfolio

February 7, 2026
CrossFirst Bankshares Stock
Analysis

A New Chapter for First Busey as CrossFirst Merger Finalizes

February 7, 2026
Golden Entertainment Stock
Gaming & Metaverse

Golden Entertainment to Exit Public Markets in Strategic Privatization Deal

February 7, 2026
Next Post
Western Digital Stock

Western Digital Shares Reach New Highs Amid Executive Stock Sales

Upstart Holdings Stock

Upstart Holdings Faces Mounting Investor Concerns Despite Strong Quarterly Performance

Oatly Stock

Oatly's Path to Sustainable Profitability Faces Market Scrutiny

Recommended

Super Micro Computer Stock

Super Micro Stock Surges Amid AI Infrastructure Boom

4 months ago
Adobe Stock

Adobe’s AI Ambitions Face Investor Skepticism

4 months ago
IBM Stock

Strong IBM Earnings Fail to Impress Market as Key Segment Shows Weakness

4 months ago
Inozyme Pharma Inc Stock

Inozyme Pharma Acquisition Finalized: Strategic Focus Shifts to Clinical Development

5 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Myers Industries Set to Report Full-Year and Q4 2025 Results

OneSpan Strengthens Mobile Security Arsenal with Strategic Acquisition

Riley Exploration Permian Bolsters Board with Industry Veteran Amid Shareholder Activity

Great Lakes Dredge & Dock: A Cash Flow Inflection Point Approaches

Investors Await March Report for Boston Omaha’s Strategic Direction

Universal Insurance Maintains Quarterly Payout Amid Sector Headwinds

Trending

Orthofix Medical Stock
Earnings

Orthofix Medical Strengthens Scientific Foundation for Biologics Portfolio

by Rodolfo Hanigan
February 7, 2026
0

Investor attention turns to Orthofix Medical as the company bolsters the clinical support for its biologics business...

CrossFirst Bankshares Stock

A New Chapter for First Busey as CrossFirst Merger Finalizes

February 7, 2026
Golden Entertainment Stock

Golden Entertainment to Exit Public Markets in Strategic Privatization Deal

February 7, 2026
Myers Industries Stock

Myers Industries Set to Report Full-Year and Q4 2025 Results

February 7, 2026
OneSpan Stock

OneSpan Strengthens Mobile Security Arsenal with Strategic Acquisition

February 7, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Orthofix Medical Strengthens Scientific Foundation for Biologics Portfolio
  • A New Chapter for First Busey as CrossFirst Merger Finalizes
  • Golden Entertainment to Exit Public Markets in Strategic Privatization Deal

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com